Navigation Links
New Test Identifies Candidates For Cardiac Defibrillator

Several lives were saved in the US in 2005 from the fatal arrhythmias through devices which were surgically implanted in them. // As many as 1,70,000 people in North America received this treatment. Quite a few of the patients also found this to be uncomfortable, unnecessary, and even dangerous. A noninvasive test has been developed recently to find out which of the patients are likely to benefit from the implantable cardiac defibrillator (ICD).

The test was found to be accurate by a study which was sponsored by the NIH with the active participation of researchers belonging to the Columbia University Medical Center. The American College of Cardiology’s journal has reported the findings of the study. The heart’s electrical activity is measured by the Microvolt T-wave Alternans (MTWA) test, when even a minor physical exercise is being performed by the patient. Threatening rhythm disturbances which the traditional electrocardiogram (ECG) is incapable of detecting can easily be identified by the MTWA test.

This will contribute towards identifying those people who belong to the high-risk category even though they may not yet have suffered from a cardiac arrest. A pulse of electrical current will be delivered through the device if an arrhythmia were to occur in a patient. The study was conducted on 549 patients over a period of two years. As the ICD implantations cost as much as $50,000, the MTWA test will contribute towards scaling down healthcare expenses. The test is estimated at only $400.


'"/>




Page: 1

Related medicine news :

1. Research Identifies The Causes Of Snoring
2. Research Identifies Osteoporosis Controlling Protein
3. New Technique Identifies Unknown Genetic Mutations That Can Cause Cancer
4. Study Identifies Mechanism Which May Help Tamoxifen Work Better
5. 3-D Ultrasound Identifies Women at Risk for Impending Preterm Birth
6. Novel Test Identifies Leukemia Patients Likely to Respond to New Therapy
7. New Screening Protocol Identifies More Case Of Lynch Syndrome
8. PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery
9. Study Identifies Risk Factors for Spread of Respiratory Infections in Hospitals
10. Study Identifies Multiple Genetic Risk Factors for Prostate Cancer
11. Reservation For SC/ST Candidates Under 50% All India Quota
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology: